Close-up of dark red grapes against a warm brown background

Research

OPC from grape seeds: what is established, what is not?

13 min read

-1.54 mmHg, -6.08 mmHg and no established effect: these are the 3 results that 3 meta-analyses reached on grape seed extract and systolic blood pressure.1-3 A second finding adds to this. Of the long molecular chains in the extract, practically nothing reaches the blood unchanged in the small intestine.4,5

Anyone wanting to know what grape seed extract can do in the body should therefore not start by asking how strongly it scavenges radicals in a test tube. The better question is: what actually arrives in the body? This article follows that question, from chain length and the gut microbiome to blood pressure, blood vessels, veins and the first guideline on flavan-3-ols.

What is OPC?

OPC stands for oligomeric proanthocyanidins. Proanthocyanidins are chains of flavan-3-ols, above all catechin and epicatechin.4 The same building blocks are found in tea, pome fruit, berries and cocoa.6 In green tea extract they occur mostly as single units. In grape seeds they are joined into chains, and the length of these chains is the most important difference.

Grape seeds in a white dish next to halved red grapes
Grape seeds: here the building blocks of OPC are linked into chains.

The trade name OPC covers only part of what is actually in the jar.

"Oligomeric" describes short chains of a few units. Grape seed extract, however, also contains polymeric proanthocyanidins with considerably more building blocks.7 That is no quibble. How long a chain is decides where in the digestive tract it is broken down and whether anything reaches the blood at all.4,5

How much proanthocyanidin does a person normally eat?

A European evaluation based on the consumption database of the European Food Safety Authority quantified the habitual intake of adults in 14 countries. For proanthocyanidins it ranged from 96 mg a day in the Netherlands to 175 mg in Spain. Counting all flavan-3-ols together, the range was between 181 mg in the Czech Republic and 793 mg in Ireland.6

For all flavan-3-ols together, tea was the main source (62 per cent), followed by pome fruit (11 per cent), berries and cocoa products (3 per cent each). For proanthocyanidins alone, pome fruit came first (28 per cent). The authors note that usual intake lies considerably below the amounts used in most intervention studies.6

Red apples in front of a glass teapot and a cup of tea, with sprigs of red berries
For proanthocyanidins alone, pome fruit was the leading source.

How much OPC does the body absorb?

This is where the real finding begins. A review of the absorption, distribution, metabolism and excretion of procyanidins sums up: chains with more than 4 units are not directly absorbed in the small intestine. Only single building blocks and, to a small extent, dimers appear in plasma, mostly as methylated and glucuronidated metabolites.4

A randomised cross-over study in humans shows how clear this is. It compared pure epicatechin, the dimer procyanidin B1 and polymeric procyanidins directly. After the dimer and the polymers, single building blocks were not detectable in plasma or urine.5

What reaches the blood depends on chain length

Uptake in humans by number of building blocks (flavan-3-ol units)

1 unit (monomer)catechin, epicatechin; in blood mainly as metabolitesabsorbed
2 units (dimer)e.g. procyanidin B1; only small amounts in plasmain traces
More than 4 unitsnot directly absorbed in the small intestinenot directly
Breakdown product from the colona valerolactone, formed by gut bacteriawell measurable
Sources: Zhang et al. 2016 (review), Wiese et al. 2015 (randomised cross-over study in humans).

What role does the gut microbiome play?

What is not absorbed in the small intestine does not disappear. It reaches the colon, where bacteria break the chains down into smaller phenolic compounds.4 The most important of these is 5-(3',4'-dihydroxyphenyl)-γ-valerolactone. In the same cross-over study it was the dominant metabolite in blood and urine, and how much of it was formed varied widely from person to person.5

A randomised, placebo-controlled study with 69 volunteers who took grape seed polyphenols (1,000 mg a day) for 6 weeks shows that this route is really taken. Urinary excretion of 3-hydroxyphenylpropionic acid rose consistently, a sign of bacterial breakdown of the proanthocyanidins.8

A laboratory study from 2023 followed the mechanism further. After oxidation, the valerolactone activates the Nrf2 pathway in cells, through which cells switch on their own protective systems. The authors classify this as parahormesis: it is not the absorbed antioxidant that scavenges radicals, but its breakdown product that triggers the body's own response.7 This does not show that the route works in humans.

Why does not everyone respond to grape seed extract in the same way?

If bacteria must first convert the compound, the response can differ from person to person. The PRECISE study points in this direction: a double-blind cross-over study in 14 adults aged 45 and over with overweight and an increased risk of diabetes, 12 weeks per phase. The product contained 300 mg of grape seed and 250 mg of bilberry extract a day. Mean 24-hour blood pressure fell by 4.7 mmHg systolic and 2.3 mmHg diastolic.9

8 of the 14 participants responded with lower blood pressure, 6 did not. The responders already had a different gut flora composition at the start and more phenolic breakdown products in their stool.9 14 people are few, and the contribution of the grape seed extract cannot be separated from that of the bilberry. As a hint at why larger studies turn out so inconsistently, the finding is nonetheless revealing.

What do studies show on grape seed extract and blood pressure?

The best-studied endpoint is blood pressure. It also shows how much the choice of studies determines a result.1-3

A meta-analysis from 2011 pooled 9 randomised trials with 390 participants: systolic -1.54 mmHg, heart rate -1.42 beats per minute. It found no effect on the diastolic value, blood lipids or C-reactive protein.1

A second analysis from 2016 evaluated 16 trials with 810 participants and arrived at a multiple: systolic -6.08 mmHg, diastolic -2.80 mmHg.2

The most comprehensive analysis so far included 19 trials. It found a fall in the diastolic value (-2.20 mmHg) and in heart rate. For systolic blood pressure, however, it found no statistically established effect (-3.55 mmHg; confidence interval -7.59 to 0.49).3

3 meta-analyses, 3 results

Change in systolic blood pressure with grape seed extract in mmHg, with 95% confidence interval

Feringa 2011 -1.549 trials, 390 participants
Zhang 2016 -6.0816 trials, 810 participants
Foshati 2022 -3.5519 trials, not significant
-12-8-40

MeanConfidence intervalLine at 0 = no change

Sources: Feringa et al. 2011, Zhang et al. 2016, Foshati et al. 2022. If the interval crosses 0, the effect is not statistically established.

All 3 are meta-analyses of randomised trials, so the same level of scientific evidence. They contradict one another because they included different trials. The spread explains why: for the systolic value, heterogeneity in the most recent analysis was 97.4 per cent. The included trials are hardly comparable.3

What do dose, duration and starting value contribute?

The subgroups show a clearer picture than the overall values. In the 2016 meta-analysis the fall was larger in people under 50, with overweight and with metabolic syndrome. Age, body weight and baseline blood pressure were associated with the size of the effect.2 For the diastolic value, the most recent analysis found non-linear relationships with dose and with duration of intake.3

A randomised trial in people with high-normal blood pressure used 300 mg a day for 6 weeks. Systolic pressure fell by 5.6 per cent and diastolic by 4.7 per cent; those who started higher saw a fall nearly twice as large. The most telling part comes at the end: 4 weeks after stopping, the values were back at baseline.10 Another trial with the same daily amount over 16 weeks in healthy people pointed in the same direction.11

What do studies show on vascular function?

If grape seed extract acts via the blood vessels, this should show in flow-mediated dilation, the standard measure of the function of the inner vessel wall (endothelium). The most recent meta-analysis tested exactly this: +1.02 per cent, confidence interval -0.62 to 2.66. No statistically established effect, with heterogeneity of 92 per cent.3

The single trial in people with high-normal blood pressure also found no change in vessel dilation. Oxidised LDL cholesterol and adhesion molecules stayed the same too, even though blood pressure fell in the same trial.10 In cell culture, by contrast, an adhesion molecule and endothelin-1 could be lowered markedly.11 The gap between cell culture and humans is particularly well documented here.

What is established on blood lipids and metabolism?

On blood lipids the picture is weaker. The 2011 meta-analysis found no effect on blood lipids.1 A systematic review from 2021 included 20 studies on grape seed extract. It judges more cautiously: total and LDL cholesterol might fall, but only in certain groups. It names people with raised baseline values, type 2 diabetes or metabolic syndrome.12

A randomised trial in 40 adults with overweight found more favourable HDL and LDL cholesterol values over 12 weeks. However, it ran together with a calorie-restricted diet in both groups. The extract's own contribution outside a diet cannot be read from it.13

What does the Cochrane review on venous remedies show?

Grape seed extract is often linked with venous complaints, citing a Cochrane review. The 2020 review included 69 randomised trials of venous remedies (phlebotonics), 56 of them with usable data from 7,690 participants. For the class as a whole it found a slight reduction in swelling and ankle circumference, with moderate certainty of evidence. At the same time there were slightly more adverse events than with placebo, mostly gastrointestinal. The trials provided only short-term data.14

The breakdown is decisive: 28 trials examined rutosides, 11 hidrosmine and diosmine, 10 calcium dobesilate and just one grape seed extract. Anyone citing the Cochrane finding for grape seed extract transfers the result of an entire class to a member that hardly appears in it.14

Only 1 of 56 trials in the Cochrane review on venous remedies concerned grape seed extract

Number of trials with usable data per substance

Rutosides28
Hidrosmine and diosmine11
Calcium dobesilate10
Centella asiatica2
Aminaftone2
French maritime pine bark extract2
Grape seed extract1
Source: Martinez-Zapata et al. 2020, Cochrane Database of Systematic Reviews; 56 trials with 7,690 participants. The result applies to the class, not to a single substance.

What does the first guideline on flavan-3-ols recommend?

In 2022 an expert panel following the process of the Academy of Nutrition and Dietetics published the first ever guideline on a dietary bioactive plant compound. It was based on 157 randomised trials and 15 cohort studies. The result was moderate evidence for an intake of 400 to 600 mg of flavan-3-ols a day. The evidence was strongest for systolic blood pressure, total and HDL cholesterol and insulin and glucose values.15

One sentence of the guideline is rarely quoted in advertising. It is expressly a food-based guideline and not a recommendation for flavan-3-ol supplements.15 How diet and supplements relate to each other in general is covered in Diet or supplements.

What does "95% OPC" on the label say?

A statement such as "95% OPC" quantifies how much proanthocyanidin an extract contains in total. It says nothing about how long their chains are. According to the available data, that is exactly what decides whether a molecule is absorbed in the small intestine or must first be broken down in the colon.4,5

2 products with the same percentage can therefore differ in what is measurable in the end. The daily amount used and the standardisation say more. The percentage is a total, not a statement about composition.

Is there an authorised health claim for OPC?

No. The EU list of permitted health claims contains no claim for grape seed extract or oligomeric proanthocyanidins.16 What studies measure is therefore not a statement a product may advertise with. How this list is drawn up is explained in the article on EU health claims. Other polyphenols with a similarly mixed evidence base are quercetin and resveratrol.

What studies on grape seed extract have measured

Meta-analyses and reviews of randomised trials

Systolic blood pressure3 meta-analyses, 9 to 19 trialsinconsistent
Diastolic blood pressurefall in 2 of 3 meta-analysesinconsistent
Heart rate2 meta-analyses, about 1 to 1.5 beats per minutefall measured
Vessel dilation (FMD)meta-analysis, interval includes 0not established
Blood lipidsno effect 2011; 2021 only in subgroupsinconsistent
Venous complaints1 trial in the Cochrane reviewbarely studied
Sources as in the sections above: Feringa 2011, Zhang 2016, Foshati 2022, Grohmann 2021, Martinez-Zapata 2020. A measured effect is not an authorised health claim.

Key takeaways

  • OPC stands for oligomeric proanthocyanidins, chains of flavan-3-ols, the same building blocks as in tea and cocoa. Grape seed extract also contains longer chains that the name does not cover.4,7
  • Chains with more than 4 units are not directly absorbed in the small intestine. What is measurable in the blood is mainly breakdown products of gut bacteria, above all a valerolactone.4,5,8
  • For systolic blood pressure, 3 meta-analyses reach 3 different results: -1.54 mmHg, -6.08 mmHg and no established effect. Heterogeneity is up to 97 per cent.1-3
  • Flow-mediated dilation showed no established finding in the meta-analysis. The Cochrane review on venous remedies contains only 1 trial on grape seed extract.3,14
  • The first guideline on flavan-3-ols names 400 to 600 mg a day, expressly food-based and not as a recommendation for supplements.15
  • There is no authorised health claim for OPC in the EU.16

Sources

  1. Feringa HH et al. The effect of grape seed extract on cardiovascular risk markers: a meta-analysis of randomized controlled trials. J Am Diet Assoc, 2011.
  2. Zhang H et al. The impact of grape seed extract treatment on blood pressure changes: a meta-analysis of 16 randomized controlled trials. Medicine (Baltimore), 2016.
  3. Foshati S et al. The effect of grape (Vitis vinifera) seed extract supplementation on flow-mediated dilation, blood pressure, and heart rate: a systematic review and meta-analysis of controlled trials with duration- and dose-response analysis. Pharmacol Res, 2022.
  4. Zhang L et al. The absorption, distribution, metabolism and excretion of procyanidins. Food Funct, 2016.
  5. Wiese S et al. Comparative biokinetics and metabolism of pure monomeric, dimeric, and polymeric flavan-3-ols: a randomized cross-over study in humans. Mol Nutr Food Res, 2015.
  6. Vogiatzoglou A et al. Assessment of the dietary intake of total flavan-3-ols, monomeric flavan-3-ols, proanthocyanidins and theaflavins in the European Union. Br J Nutr, 2014.
  7. Baron G et al. Unraveling the parahormetic mechanism underlying the health-protecting effects of grapeseed procyanidins. Redox Biol, 2023.
  8. Ward NC et al. Supplementation with grape seed polyphenols results in increased urinary excretion of 3-hydroxyphenylpropionic acid, an important metabolite of proanthocyanidins in humans. J Agric Food Chem, 2004.
  9. Grohmann T et al. A grape seed and bilberry extract reduces blood pressure in individuals at risk of developing type 2 diabetes: the PRECISE study. Front Nutr, 2023.
  10. Park E et al. Effects of grape seed extract beverage on blood pressure and metabolic indices in individuals with pre-hypertension: a randomised, double-blinded, two-arm, parallel, placebo-controlled trial. Br J Nutr, 2016.
  11. Schön C et al. Grape seed extract positively modulates blood pressure and perceived stress: a randomized, double-blind, placebo-controlled study in healthy volunteers. Nutrients, 2021.
  12. Grohmann T et al. Efficacy of bilberry and grape seed extract supplement interventions to improve glucose and cholesterol metabolism and blood pressure in different populations - a systematic review of the literature. Nutrients, 2021.
  13. Yousefi R et al. Grape seed extract supplementation along with a restricted-calorie diet improves cardiovascular risk factors in obese or overweight adult individuals: a randomized, placebo-controlled trial. Phytother Res, 2021.
  14. Martinez-Zapata MJ et al. Phlebotonics for venous insufficiency. Cochrane Database Syst Rev, 2020.
  15. Crowe-White KM et al. Flavan-3-ols and cardiometabolic health: first ever dietary bioactive guideline. Adv Nutr, 2022.
  16. European Union. Commission Regulation (EU) No 432/2012 establishing a list of permitted health claims made on foods, Annex. Official Journal of the European Union L 136, 25.05.2012.

ATLAS All-in-One - 35 ingredients, 4 capsules, once a day.